SThree (LON:STEM – Get Free Report) released its quarterly earnings data on Tuesday. The company reported GBX 37.40 ($0.47) earnings per share (EPS) for the quarter, Digital Look Earnings reports. SThree had a net margin of 3.53% and a return on equity of 26.60%.
SThree Stock Down 1.5 %
Shares of STEM traded down GBX 4 ($0.05) during midday trading on Thursday, hitting GBX 260 ($3.24). 624,886 shares of the company’s stock traded hands, compared to its average volume of 385,407. The company has a current ratio of 1.89, a quick ratio of 1.69 and a debt-to-equity ratio of 11.91. The stock has a market capitalization of £345.54 million, a price-to-earnings ratio of 619.05, a price-to-earnings-growth ratio of 0.75 and a beta of 0.98. SThree has a 1 year low of GBX 221.50 ($2.76) and a 1 year high of GBX 457.50 ($5.70). The firm’s fifty day moving average is GBX 301.47 and its 200-day moving average is GBX 358.53.
Insider Buying and Selling
In other news, insider Elaine ODonnell acquired 5,500 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were bought at an average cost of GBX 344 ($4.28) per share, for a total transaction of £18,920 ($23,555.78). Also, insider Andrew Beach bought 9,436 shares of SThree stock in a transaction dated Tuesday, December 17th. The stock was acquired at an average price of GBX 265 ($3.30) per share, with a total value of £25,005.40 ($31,132.22). Insiders have acquired a total of 15,022 shares of company stock worth $4,419,450 in the last ninety days. 6.23% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on STEM
About SThree
SThree plc brings skilled people together to build the future. We are the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics (‘STEM’), providing permanent and flexible contract talent to a diverse base of over 7,200 clients across 11 countries. Our Group’s c.2,600 staff cover the Technology, Life Sciences and Engineering sectors.
Read More
- Five stocks we like better than SThree
- What Do S&P 500 Stocks Tell Investors About the Market?
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- With Risk Tolerance, One Size Does Not Fit All
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
Receive News & Ratings for SThree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SThree and related companies with MarketBeat.com's FREE daily email newsletter.